Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BBH | 72.73% | $329.82M | 0.35% |
FHLC | 68.95% | $2.43B | 0.084% |
XLV | 68.79% | $34.14B | 0.09% |
IYH | 68.52% | $2.71B | 0.39% |
VHT | 68.38% | $15.31B | 0.09% |
IXJ | 67.96% | $3.74B | 0.41% |
RSPH | 66.60% | $731.31M | 0.4% |
IBB | 64.68% | $5.36B | 0.45% |
PPH | 63.90% | $614.42M | 0.36% |
FXH | 63.08% | $898.02M | 0.62% |
FBT | 60.85% | $1.01B | 0.54% |
IHE | 60.84% | $557.07M | 0.39% |
PBE | 60.23% | $223.24M | 0.58% |
SCHD | 58.94% | $68.70B | 0.06% |
XPH | 56.60% | $149.79M | 0.35% |
FDL | 56.21% | $5.39B | 0.43% |
HDV | 55.78% | $10.97B | 0.08% |
FVD | 55.40% | $8.94B | 0.61% |
DHS | 55.01% | $1.22B | 0.38% |
NOBL | 54.90% | $11.27B | 0.35% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
PFE | 57.68% | $137.53B | -13.55% | 7.04% |
BIIB | 55.88% | $18.47B | -45.61% | 0.00% |
IQV | 55.02% | $27.24B | -25.53% | 0.00% |
TECH | 54.31% | $8.13B | -27.65% | 0.62% |
TMO | 53.62% | $154.12B | -26.17% | 0.40% |
GSK | 52.24% | $78.10B | +0.21% | 4.17% |
ZTS | 50.87% | $69.53B | -9.92% | 1.20% |
ABBV | 50.14% | $322.03B | +6.29% | 3.50% |
RVTY | 49.94% | $11.53B | -6.71% | 0.29% |
NVS | 49.07% | $227.73B | +12.73% | 3.32% |
MTD | 48.91% | $24.62B | -15.24% | 0.00% |
LH | 48.63% | $21.80B | +28.05% | 1.10% |
GILD | 48.31% | $137.67B | +61.30% | 2.84% |
QGEN | 48.19% | $10.34B | +13.03% | 0.00% |
DHR | 47.74% | $142.28B | -20.43% | 0.73% |
LIN | 47.45% | $218.32B | +5.69% | 1.24% |
KHC | 47.13% | $30.31B | -20.52% | 6.25% |
PEP | 47.07% | $179.67B | -20.55% | 4.19% |
MEDP | 46.73% | $8.93B | -24.56% | 0.00% |
A | 46.13% | $33.85B | -8.07% | 0.81% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
BTCT | -20.33% | $18.98M | +37.85% | 0.00% |
MNOV | -13.49% | $65.23M | -7.64% | 0.00% |
HUSA | -10.22% | $22.94M | -6.82% | 0.00% |
SPTN | -8.27% | $897.34M | +41.31% | 3.31% |
TLN | -7.42% | $13.56B | +168.31% | 0.00% |
MVO | -6.86% | $66.13M | -38.96% | 21.90% |
DFDV | -5.88% | $247.94M | +1,821.34% | 0.00% |
AIFU | -5.62% | $6.13B | +82.50% | 0.00% |
ALAR | -5.60% | $90.19M | -69.19% | 0.00% |
LRN | -5.44% | $6.34B | +106.55% | 0.00% |
RLX | -4.80% | $2.02B | +20.65% | 0.45% |
STG | -4.24% | $29.06M | -28.79% | 0.00% |
CLLS | -3.98% | $104.54M | -22.46% | 0.00% |
HTZ | -3.96% | $1.00B | +100.28% | 0.00% |
SYPR | -3.77% | $52.86M | +19.79% | 0.00% |
CEG | -3.69% | $100.35B | +59.87% | 0.46% |
QNRX | -3.57% | $5.45M | -54.34% | 0.00% |
VHC | -3.02% | $45.90M | +59.26% | 0.00% |
UUUU | -2.69% | $1.20B | -8.42% | 0.00% |
POAI | -1.96% | $7.41M | -20.20% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
LEU | 0.01% | $2.87B | +294.50% | 0.00% |
AXON | -0.04% | $63.73B | +178.21% | 0.00% |
BVN | -0.08% | $4.10B | -4.72% | 0.00% |
PAYO | 0.25% | $2.40B | +19.68% | 0.00% |
ZVIA | 0.27% | $240.48M | +439.10% | 0.00% |
GALT | 0.32% | $147.47M | +3.10% | 0.00% |
ANET | 0.34% | $124.83B | +13.43% | 0.00% |
QBTS | 0.34% | $4.38B | +1,129.82% | 0.00% |
OXBR | -0.39% | $13.03M | -26.47% | 0.00% |
CMP | 0.42% | $833.66M | +93.90% | 0.00% |
CREG | -0.48% | $5.81M | -77.49% | 0.00% |
K | -0.49% | $27.41B | +36.96% | 2.88% |
WRAP | 0.49% | $79.91M | -21.00% | 0.00% |
AGX | -0.54% | $3.00B | +200.36% | 0.64% |
VST | -0.55% | $66.18B | +126.84% | 0.45% |
SHOP | -0.57% | $147.45B | +72.07% | 0.00% |
TH | -0.60% | $712.44M | -17.68% | 0.00% |
CNTY | 0.63% | $73.02M | -14.08% | 0.00% |
PULM | 0.66% | $25.57M | +262.69% | 0.00% |
SE | -0.66% | $87.06B | +123.06% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XONE | -0.05% | $585.86M | 0.03% |
WEAT | -0.63% | $117.15M | 0.28% |
SHYM | -0.68% | $350.04M | 0.35% |
DBA | -0.85% | $797.06M | 0.93% |
FXE | -1.16% | $568.58M | 0.4% |
USFR | 1.21% | $18.51B | 0.15% |
URNM | 1.32% | $1.74B | 0.75% |
USL | 1.59% | $42.26M | 0.85% |
URNJ | 1.61% | $304.99M | 0.8% |
FXY | 1.67% | $815.67M | 0.4% |
KCCA | -1.88% | $105.63M | 0.87% |
IBDQ | 1.92% | $2.99B | 0.1% |
IBTF | -1.94% | $2.02B | 0.07% |
UGA | 1.98% | $72.51M | 0.97% |
SHV | 2.16% | $20.67B | 0.15% |
GBIL | -2.18% | $6.38B | 0.12% |
UUP | -2.36% | $211.55M | 0.77% |
SPTS | 2.38% | $5.78B | 0.03% |
AGZD | 2.54% | $102.66M | 0.23% |
BOXX | -2.68% | $6.72B | 0.19% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -28.74% | $165.69M | 0.85% |
TAIL | -24.58% | $99.76M | 0.59% |
CLIP | -20.41% | $1.52B | 0.07% |
ULST | -15.47% | $662.59M | 0.2% |
IVOL | -12.07% | $349.27M | 1.02% |
CANE | -11.56% | $10.44M | 0.29% |
TFLO | -10.83% | $6.83B | 0.15% |
TPMN | -9.34% | $30.81M | 0.65% |
XHLF | -6.64% | $1.73B | 0.03% |
CTA | -4.68% | $1.06B | 0.76% |
FTSD | -4.33% | $231.79M | 0.25% |
USDU | -4.28% | $162.92M | 0.5% |
TBLL | -4.05% | $2.13B | 0.08% |
BTAL | -3.96% | $296.79M | 1.43% |
FMF | -3.74% | $155.81M | 0.95% |
BIL | -3.18% | $42.87B | 0.1356% |
BOXX | -2.68% | $6.72B | 0.19% |
UUP | -2.36% | $211.55M | 0.77% |
GBIL | -2.18% | $6.38B | 0.12% |
IBTF | -1.94% | $2.02B | 0.07% |
Yahoo
President Trump and Elon Musk continue to feud. Nike and Apple boost the Dow.
Yahoo
The placebo-controlled trial involved 547 subjects across 300 sites in 37 nations.
Yahoo
Protagonist Therapeutics is taking aim directly at Eli Lilly's obesity treatment with a newly announced drug that uses the same mechanism.
Finnhub
Amgen announced the Phase 3 FORTITUDE-101 clinical trial evaluating first-line bemarituzumab plus chemotherapy met its primary endpoint of overall survival at a pre-specified interim analysis....
Yahoo
Amgen (NASDAQ:AMGN) today announced the Phase 3 FORTITUDE-101 clinical trial evaluating first-line bemarituzumab plus chemotherapy (mFOLFOX6) met its primary endpoint of overall survival (OS) at a pre-specified interim analysis.
Finnhub
By Connor Hart Amgen said a Phase 3 trial of its gastric cancer treatment, bemarituzumab, met its primary endpoint of overall survival at a pre-specified interim analysis. The biotechnology...
Double maintains 15 strategies that include AMGN - Amgen, Inc.
Current Value
$278.851 Year Return
Current Value
$278.851 Year Return